International Journal of Generic Drugs
Publishes publishes articles reviews and papers on various aspects of Generic and Innovative Drug Development from pre-formulation to aspects of regulatory strategy.
Price: $ 1,299.00
Aug 05 2010
i’m on my 2nd coarse of accutane. using generic brand called Claravis 40 mg….?
Question by msz5128: i’m on my 2nd coarse of accutane. using generic brand called Claravis 40 mg….?
but i seem to be more prone to anger when i’m on this medication. i snap easily, can throw tantrums and have a bad temper. i’m not usually like this. is this a side effect? is it normal?
don’t get me wrong. accutane worked MIRACLES on me when i went on my first coarse last year in the month of March. it’s true when they call it the “miracle drug.” i saw results in two months. i had beautiful flawless looking skin. even more beautiful than my friends who didn’t suffer from acne! everyone had noticed the change in my appearance and confidence. up until a few months ago i noticed a few pimples starting to come out here and there as well as some redness. i was disappointed and decided to get back on it asap before it becomes worse.
Best answer:
Answer by photoquilty
First things first: you meant to say “course”, not “coarse”. Look it up.
Secondly, if you feel that the accutane is causing your unreliable behavior, you must tell this to your doctor. There’s no question about letting this go on. If a medication can actually make you a different person (for the worse) then there is absolutely no reason to keep taking it. If you’re concerned about the acne, find another way to fight it. It’s not worth losing your personality.
Add your own answer in the comments!
Comments Off
Aug 05 2010
Latest Generic Drugs News
Senate panel bans payments to delay generics
WASHINGTON (AP) – In a defeat for the powerful drug lobby, a Senate panel approved legislation to prohibit drug companies from paying generic drug makers to delay bringing less costly products to market.
Read more on Ventura County Star
Senate panel bans payments to delay generics
In a defeat for the powerful drug lobby, a Senate panel approved legislation to prohibit drug companies from paying generic drug makers to delay bringing less costly products to market.
Read more on Channel 8 San Diego
Senate panel bans payments to delay generics
In a defeat for the powerful drug lobby, a Senate panel approved legislation to prohibit drug companies from paying generic drug makers to delay bringing less costly products to market.
Read more on KSWO Lawton-Wichita Falls
Comments Off
Aug 04 2010
Latest Generic Drugs News
Bayer’s 2nd-quarter profit down 1.3 percent
Germany’s Bayer AG saw second-quarter net earnings slip by 1.3 percent as a stronger revenue was offset by one-time charges for lawsuits and writing down a cancer drug.
Read more on KSWO Lawton-Wichita Falls
AstraZeneca doubles buyback as Brilinta shines
By Ben Hirschler
Read more on Interactive Investor
BD third-quarter revenues increase 3.2% to .878 billion
BD, a leading global medical technology company, today reported quarterly revenues of $ 1.878 billion for the third fiscal quarter ended June 30, 2010, representing an increase of 3.2 percent from the prior-year period, or 3.9 percent on a foreign currency-neutral basis.
Read more on News-Medical-Net
Comments Off
Aug 04 2010
Latest “generic Drugs” News
K-V Pharmaceutical Company Engages BDO USA, LLP as Independent Registered Accountants
K-V Pharmaceutical Company announced today that the Audit Committee of its Board of Directors has engaged BDO USA, LLP as the Company’s independent registered accounting firm.
Read more on PR Newswire via Yahoo! Finance
KV claims patent infringement in lawsuit
KV Pharmaceutical sued the maker of generic drugs Perrigo Co., alleging patent infringement with its plans to make low-cost copies of the drug Gynazole used to treat female yeast infections.
Read more on St. Louis Post-Dispatch
Support for prescription drug costs is out there
You may need to be logged in to see stories listed here that are in our archives. ASHEBORO — Paying for health care is a frequent worry for Americans.
Read more on Asheboro Courier-Tribune
Comments Off
Aug 04 2010
Latest Generic Drugs News
CVS announces deal with Aetna, 2Q profit falls
CVS Caremark Corp. Wednesday reported weaker quarterly earnings and lowered its profit forecast, but shares roseas investors approved of a large pharmacy benefit management services contract struck with Aetna.
Read more on FOX 12 Idaho
Comments Off
Aug 03 2010
Generic Drug Development: Solid Oral Dosage Forms
Generic Drug Development: Solid Oral Dosage Forms
Keeping pace with the latest technologies in the field, this guide describes the development of solid oral generic drug products from project initiation to market approval. Focusing on immediate-release and modified-release dosage forms, the book collects in-depth discussions from more than 30 noted specialists on topics such as quality control, experimental formulation, pharmaceutical ingredients, and bioequivalence, and considers key elements in the formulation of generic drug products includi
List Price: $ 229.95
Price:
Comments Off
Aug 03 2010
Does anyone know if there is a generic version of the opiate dependance drug “Suboxone”?
Question by pzb531: Does anyone know if there is a generic version of the opiate dependance drug “Suboxone”?
Best answer:
Answer by dragfanbob
try methadone
What do you think? Answer below!
Comments Off
Aug 03 2010
Latest Generic Drugs News
Sanofi May Need to Bid Up to .3 Billion to Win Over Genzyme Investors
Sanofi-Aventis SA may have to pay at least $ 80 a share, or $ 21.3 billion, to acquire genetic-disease drugmaker Genzyme Corp. as activist directors drive up the price, investors in the U.S. biotechnology company say.
Read more on Bloomberg
Comments Off
Aug 02 2010
Latest Generic Drugs News
Penwest Second Quarter 2010 Financial Results Conference Call
PATTERSON, N.Y. — Penwest Pharmaceuticals Co. will conduct a conference call on Wednesday, August 4, at 11:00 a.m. EDT to review its financial results for the second quarter of 2010, which will be released earlier that day.
Read more on GlobeNewswire via Yahoo! Finance
Comments Off
« Previous Page — Next Page »
